NDUFB2, HSP90B1, and LITAF in Astrocytes Can Serve as Key Indicators for Overall Survival in Glioblastoma Patients
This study identifies NDUFB2, HSP90B1, and LITAF as independent prognostic biomarkers in glioblastoma by characterizing astrocyte metabolic activation and immune microenvironment modulation through integrated single-cell and spatial transcriptomics analyses.